life scienc diagnost industri offer attract
growth moat wari valuat
page full analyst note
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research
estim sep
price data jan
rate updat jan
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
bigger alway better thermo fisher nonetheless
maintain torrid pace acquisit ultim goal
becom go-to provid life scienc instrument
consum recent firm acquir affymetrix fei
close billion acquisit patheon remain
cautiou regard growth-via-acquisit strategi
yet see evid billion compani
spent acquisit sinc yield benefit
return invest capit
acquisit strategi allow firm significantli
broaden product offer turn allow steadili
gain market share one-stop shop approach afford price
flexibl result strong custom relationship
compani find recept audienc larg pharma client
see sizabl benefit simplifi procur process
thermo fisher offer result firm penetr pharma
expand expect continu even see
deceler biopharma spend growth torrid current
thermo fisher emerging-market presenc also impress
grow rapidli total sale firm significantli
expand manufactur footprint area allow
compet effect indigen manufactur brand
carri great power among research given on-going
commit research
life scienc
emerging-market govern compani goal expand
emerging-market busi annual appear
firm effort yield organ market share gain
core strategi remain growth acquisit
aggress clearli state capital-deploy strategi
remain risk firm could overpay yet anoth sizabl
deal fuel cheap financ said ever-expand
presenc virtual area life scienc research part
achiev acquisit afford thermo fisher opportun
capit strong secular growth expect sector
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
thermo fisher scientif sell scientif instrument laboratori
equip diagnost consum life scienc reagent firm
oper four segment analyt technolog
sale fei acquisit specialti diagnost product life
scienc solut includ affymetrix lab product servic
includ patheon exclud cross-seg sale
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
life scienc diagnost industri offer attract
growth moat wari valuat
think plenti like life scienc
sever competit advantag lead econom
moat industri tend predict
attract growth outlook especi area
bioprocess analyt instrument genom
addit somewhat insul broader
macroeconom cycl nearli everi compani life
scienc diagnost manufactur coverag also earn
econom moat thank intang often pair
high switch cost valuat alreadi reflect
optim howev multipl across industri
look expens view current think water
agil becton dickinson reflect best
valu trade close territori view mettler
biomerieux significantli overvalu
moat common life scienc tool thank intang
switch cost gener award moat life
scienc diagnost firm record consist
innov larg instal base equip
dedic pull consum
chromatographi mass spectrometri market led
water agil creat one wide-moat
segment benefit low disrupt risk high
barrier entri comfort oligopoli razor-and-
blade busi model high custom switch cost
nich ga
outlook life scienc diagnost market
remain stabl attract pocket growth
estim market exce roughli billion grow
nearli annual depend market
segment popul growth increas drug research
volum workflow improv rise manufactur
qualiti standard emerg field genet research
test key industri growth driver
complet overview life scienc moat analysi
pleas see report life scienc diagnost industri
offer attract growth econom moat wari
valuat discuss growth outlook
econom moat life scienc industri
rais fair valu estim per share
due mainli cash flow realiz sinc previou
report also slightli modifi tax rate go forward
includ patheon acquisit assumpt
account currenc tailwind revenu
organ growth expect core busi
approxim firm continu see
steadi growth biopharma spend stabl demand
academ govern custom particularli
unit state improv perform industri
end market long-term expect double-digit
growth emerg market need off-set much
matur inflationlik growth develop world
anticip modest benefit acquisit
long term forecast thermo fisher sale
increas approxim per year organ
firm like resum acquisit strategi
deleverag expect analyt instrument life
scienc segment drive futur growth matur
catalog busi provid cash flow fund
invest growth area anticip thermo fisher
adjust oper margin exclud amort
improv basi point next five year line
firm
manufactur shift lower-cost region effici
improv off-set price pressur
mani commod product
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
high-single-digit organ revenu growth firm
analyt busi low-single-digit growth
laboratori segment assumpt
conserv given concern durat
current bullish spend cycl hesit
incorpor aggress assumpt
mid-single-digit growth develop market china
deliv double-digit growth throughout forecast
signific upsid valuat posit scenario
valu compani per share
believ thermo fisher deliv acquisit
integr expect thu base-cas scenario
incorpor compani synergi forecast much
million cost save ultim much
uncertainti surround fair valu estim pertain
amount synergi well success
anticip life busi grow
averag forecast period
compani key end market biopharma hard
land develop world china deceler
fair valu estim fall per share thermo fisher
knack cost control challeng growth
environ also propens supplement
intern growth acquisit henc growth
environ remain constrain compani could opt
becom aggress acquisit front provid
addit risk share
speed magnitud recoveri industri
end market also one key variabl underli
assumpt thermo fisher expect
thermo fisher narrow moat come scale
scope busi -- enorm manufactur sale
infrastructur along broad product
offer rang scientif instrument lab
equip softwar servic steadi consolid
variou busi
instrument fisher catalog phadia dionex
life affymetrix fei patheon acquisit allow
compani market one-stop shop
research custom appeal featur laboratori
look simplifi procur function addit
life compani consum busi even
massiv entrench custom base autom
inventori manag across broad array product
strong sell point compani compani
access custom channel unparallel legaci
next-largest competitor significantli
smaller presenc also afford firm massiv
cross-sel opportun thermo fisher salesforc
also far largest industri allow
compani penetr emerg market final
distribut network give firm unmatch scale
marketplac
thermo fisher also domin posit within
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
ground larger organ come wallet
share particularli among main custom
signific switch cost result costli
up-front invest equip exceed
million train instal instrument
requir recur stream consum purchas
servic revenu therebi insul thermo fisher
full brunt capit cycl competitor pressur
hesit award thermo fisher wide econom moat
larg lack confid compani abil
persist gener return invest capit
excess cost primarili owe acquisit strategi
opt includ acquisit associ goodwil
assumpt
on-going capit deploy
requir compani use acquisit
supplement intern research develop
deal size grow larger thermo fisher increasingli
face scenario deploy capit value-dilut
manner particularli interest rate increas
thermo fisher moat widen compani
low-cost posit rais
custom compani
distribut network alreadi far largest
offer scale advantag competit continu
grow rapidli particularli low-cost manufactur
area compani strong on-the-ground presenc
china coupl alreadi well-establish bond
multi-national compani expand
market allow capit market
rapid growth also cement tight relationship
custom unlik larg instrument maker
larger compani instal base stronger
competit advantag equip busi due
switch cost high-margin recur revenu stream
final increas abil offer custom
complet solut procur need allow
thermo fisher squeez smaller peer even gain
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oth firm target market approxim billion
total sale way billion thermo
fisher largest supplier research instrument
consum
aggress acquir
compani expans strategi depend heavili
success acquisit earn number
pollut signific non-gaap adjust
othermo fisher among industri leader nearli
ubiquit research lab across globe
addit effici integr acquir
busi compani invest heavili
technolog particularli mass spectrometri
one global leader
firm diagnost busi struggl
gener momentum legaci phadia
busi strong foothold europ
growth impress
oth compani abl fuel acquisit spree via
access extrem inexpens debt gener
excess return acquisit less favor
interest rate environ might challeng
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
end thermo fisher carri billion long-
short-term debt time ebitda held
billion cash balanc sheet acquisit
fei affymetrix patheon delay manag goal
achiev target leverag time within
month complet acquisit
solvenc concern limit manag state
past would will boost debt leverag
time right opportun given current
size could give enough flexibl complet deal
compar fei decemb major matur
next five year includ billion due
billion compani gener robust cash
flow concern regard solvenc minim
furthermor compani cash flow rather
predict consum servic account
major total sale anticip thermo fisher
remain aggress acquisit share buyback
compani pay dividend rather small rel
free cash flow
firm exposur industri end market increas
vulner prolong secular downturn fei
semiconductor busi particular could sever
affect industri spend peak cycl
current declin compani key environment
instrument target market -- china india -- cut back
environment qualiti test due fiscal concern
currenc headwind could off-set thermo
recoveri life scienc market compani face
tough competit analyt instrument busi
particularli
thermo also depend research activ academia
govern could advers affect delay
fund feder nation institut
busi signific risk technolog
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
nascent final acquisit strategi continu
expos firm risk overpay inabl integr
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
believ manag team perform
ultim judg success acquisit
strategi yet produc meaning return
invest capit access cheap financ fuel
recent buy spree interest see whether
chase earn per share growth backfir rate
eventu rise think manag team fare
well integr numer acquisit deploy
cash flow value-accret way success
integr sizabl fairli expens purchas life
signific challeng ceo marc casper team
compani suggest return capit metric
discuss frequent late improv
next five year howev chronic acquisit make
promis rather murki see opportun
continu drive margin improv intern
improv synergi ignor dilut
impact acquisit believ continu
return compani emphasi adjust ep
obscur realiti acquisit play role
repres date owner name posit common share held report holder issuer
va collegeamerica gr fd amer
capit research manag compani
share
fund
share
fund
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
oct
result revenu growth organ term
result firm rais full-year guidanc revenu
earn line expect revenu growth
ep growth year year previou guidanc
revenu growth ep growth
plan slightli adjust number
better-than-expect oper
environ enough result materi chang
fair valu estim usd narrow moat
rate intact share look expens current level
end market still show favour condit across
teen growth strength product like chromatographi
mass spectrometri equip academ
govern grew midsingl digit benefit
improv fund industri appli
segment deliv high-single-digit growth led strong
perform across analyt instrument busi
geographi deliv good growth europ north
america grew high singl digit asia-pacif
deliv growth low teen china lead
growth quarter china precis
medicin molecular microscopi centr drove demand
quarter life-sci technolog
product life scienc -- special diagnost
deliv organ growth good perform
transplant clinic diagnost area oper margin
expans mix across
segment
unfavour busi mix strateg invest
offset volum result firm oper
margin basi point third quarter
last year
thermo fisher continu deliv strong result
thermo fisher scientif report organ growth
quarter busi end market contribut
maintain fair valu estim narrow
moat rate believ share current trade
end market benefit good condit quarter
strength across consum
equip academ govern end market grew
high-singl digit rate good perform
geographi industri appli custom base
deliv mid-single-digit growth strong demand
analyt instrument busi geographi china
strongest perform growth
quarter bring growth first
half trade war tariff china
affect compani sinc tariff yet target
industri north america grew mid-singl digit rang
europ grew high singl digit rang
posit news futur research govern
fund across contin
remain impress compani abil expand
oper margin volum
leverag
product basi point margin expans
quarter exclud foreign exchang acquisit
model basi point margin expans
full year forecast
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
fiscal year end decemb
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
